Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial Tumor, Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05923190
What this trial is testing

Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma

Who this might be right for
Urothelial CarcinomaMetastatic Urothelial CarcinomaLocally Advanced Urothelial Carcinoma
Fox Chase Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT02272413
What this trial is testing

Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin® Plus Chemotherapy in Patients With Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 671
Not applicableActive Not RecruitingNCT04258813
What this trial is testing

Onco-primary Care Networking to Support TEAM-based Care

Who this might be right for
Blood PressureHypertensionCancer+15 more
Duke University 313
Testing effectiveness (Phase 2)Ended earlyNCT03050060
What this trial is testing

Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer

Who this might be right for
Metastatic Kidney CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage IV Cutaneous Melanoma AJCC v6 and v7+2 more
University of Washington 21
Not applicableStudy completedNCT00771147
What this trial is testing

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

Who this might be right for
Carcinoma, Renal CellCarcinoma, Renal Cell (Advanced)
Bayer 71
Not applicableStudy completedNCT05120947
What this trial is testing

Hypofractionated Adjuvant Radiotherapy for Resected Head and Neck Cancers

Who this might be right for
Resectable Head and Neck Squamous Cell Carcinoma
Medical College of Wisconsin 18
Not applicableUnknownNCT04443049
What this trial is testing

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Institute of Liver and Biliary Sciences, India 170
Testing effectiveness (Phase 2)Looking for participantsNCT07392658
What this trial is testing

Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung Cancer
Fondazione Ricerca Traslazionale 33
Early research (Phase 1)Not Yet RecruitingNCT06823258
What this trial is testing

Pharmacokinetic Study of HS-10365 Capsule in Subjects with Hepatic Impairment and Normal Hepatic Function

Who this might be right for
NSCLC (advanced Non-small Cell Lung Cancer)
Jiangsu Hansoh Pharmaceutical Co., Ltd. 32
Not applicableLooking for participantsNCT05667948
What this trial is testing

Molecular Analysis and Treatment Options of Thymic Malignancies

Who this might be right for
Thymic Epithelial TumorThymic CarcinomaThymic Cancer
Shanghai Chest Hospital 500
Testing effectiveness (Phase 2)Ended earlyNCT00417248
What this trial is testing

Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Sorafenib for Inoperable Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Nasser Hanna, M.D. 8
Early research (Phase 1)Active Not RecruitingNCT03401385
What this trial is testing

First-in-human Study of DS-1062a for Advanced Solid Tumors (TROPION-PanTumor01)

Who this might be right for
Hormone Receptor Positive Breast CancerTriple Negative Breast CancerNon-small Cell Lung Cancer
Daiichi Sankyo Co., Ltd. 890
Testing effectiveness (Phase 2)Ended earlyNCT04322643
What this trial is testing

Intermittent Checkpoint Inhibitor Therapy In Patients With Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Case Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT01602315
What this trial is testing

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell Carcinoma
Novartis Pharmaceuticals 179
Not applicableStudy completedNCT00900835
What this trial is testing

Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer

Who this might be right for
Breast CancerColorectal CancerFatigue+3 more
City of Hope Medical Center 470
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07691476
What this trial is testing

Multicenter Single-Arm Clinical Trial of Zanzalintinib and Pembrolizumab in Subjects With Resectable Clear Cell Renal Cell Carcinoma

Who this might be right for
Patients With Locally Advanced or Metastatic But Resectable Clear Cell Renal Cell Carcinoma
Yonsei University 48
Not applicableEnded earlyNCT03922776
What this trial is testing

Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer Stage IIICFallopian Tube Cancer Stage IIICFallopian Tube Cancer Stage IV+1 more
Centre Oscar Lambret 36
Testing effectiveness (Phase 2)Ended earlyNCT06171789
What this trial is testing

PRO1107 in Patients With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerTriple Negative Breast Cancer+3 more
Genmab 33
Early research (Phase 1)Study completedNCT01005797
What this trial is testing

Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers

Who this might be right for
Renal CancerNon Small Cell Lung Cancer (NSCLC)Soft Tissue Sarcoma
Medical University of South Carolina 38
Testing effectiveness (Phase 2)Study completedNCT00771810
What this trial is testing

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
ThrombocytopeniaNeutropeniaLymphopenia+1 more
Tarix Pharmaceuticals 34
Next Page